Cancer Detection

Early Detection is a biotechnology company dedicated to advancing non-invasive cancer screening through the identification of specific biomarkers in the mucus lining. The company's proprietary technology focuses on detecting altered carbohydrates that are uniquely produced by cancer and precancerous cells, allowing for identification at the earliest possible stages. By providing a non-invasive alternative to traditional diagnostic methods, Early Detection aims to improve patient outcomes and survival rates through early intervention. Headquartered in Coronado, California, the firm is currently in the product development phase and is supported by angel investment.